期刊文献+

采用双峰驼重链抗体特异的抗血清检测不同抗原免疫骆驼过程中血清重链抗体的水平 被引量:3

The Dynamic Change of Heavey Chain Antibody in Camelus bactrianu during the Immunization with Different Antigens Assayed by Heavy Chain Antibody Specific Antiserum
下载PDF
导出
摘要 为了探究重链抗体在骆驼免疫保护中的生物学作用,本研究利用Protein G和Protein A亲和层析纯化新疆双峰驼血清中总IgG和重链抗体IgG2,并免疫昆明小白鼠制备抗双峰驼总IgG和抗双峰驼重链抗体IgG2的多抗血清;通过ELISA检测双峰驼在体液免疫应答过程中针对spaA-N、溶菌酶和蒜氨酸酶3种抗原的重链抗体的滴度变化。结果从新疆双峰驼血清中亲和层析纯化出天然重链抗体IgG2,蛋白质分子质量约为46ku;免疫昆明小白鼠后获得抗双峰驼总IgG多抗血清的效价为1∶204800,抗双峰驼重链抗体IgG2多抗血清的效价为1∶6400。在spaA-N免疫骆驼诱导的体液免疫应答过程中,重链抗体IgG2出现延迟反应。3种蛋白均能诱导抗原特异的IgG2亚类重链抗体的产生。 In order to explore heavy chain antibodies(Cb-HcAb) biological effects of immune protection in Xinjiang Camelus bactrianus.Purification of IgG subclass in camel serum by protein G and protein A affinity chromatography,and preparation of anti-camel total IgG and IgG2 antiserum by immunization of Kunming white mice.The level of spaA-N,lysozyme and alliinase specific IgG2 and total IgG in camel serum during the immunization were analyzed with ELISA.Purification of IgG2 subclass from Xinjiang Camelus bactrianus serum by affinity chromatography with molecular weight of 46 ku.Mice anti-camel total IgG serum titer and anti-IgG2 serum titer were 1∶204800 and 1∶6400 respectively.During the immunization in camel with different antigens,all antigen specific-IgG2 HcAbs were induced during the immunization in camel,in which anti-spaA-N specific IgG2 HcAb occurred delay in the process of camel humoral immune response.
出处 《中国畜牧兽医》 CAS 北大核心 2012年第4期68-72,共5页 China Animal Husbandry & Veterinary Medicine
基金 国家自然科学基金项目(31060132) 自治区科技支疆专项(201091251)
关键词 新疆双峰驼 重链抗体 IgG2 IgG2多抗血清 Camelus bactrianus heavy chain antibody IgG2 IgG2 specific anti-serum
  • 相关文献

参考文献19

  • 1夏丽洁,苏幼红,张清华,夏雪琴,刘红春,李江伟.新疆双峰驼抗血清中重链抗体的分离鉴定[J].中国农业科学,2010,43(17):3660-3666. 被引量:7
  • 2Alvarez-Rueda N,Behar G,Ferre V. Generation of llama single-domain antibodies against methotrexate,a prototypical hapten[J].Molecular Immunology,2007.1680-1690.
  • 3Baetselier P,Muyldermans S,Magez S. Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies:African trypanosomes as paradigm[J].Journal of Biological Chemistry,2004.1256-1261.
  • 4Daley L P,Gagliardo L F,Duffy M S. Application of monoclonal antibodies in functional and comparative investigations of heavy-chain immunoglobulins in new world camelids[J].Clinical and Diagnostic Laboratory Immunology,2005,(03):380-386.
  • 5David R M,J orge S,Antcn P. Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs)[J].Journal of Immunological Methods,2007,(1-2):13-25.
  • 6De Simone E A,Saccodossi N,Ferrari A. Development of ELISAs for the measurement of IgM and IgG subclasses in sera from llamas (Lama glama) and assessment of the humoral immune response against different antigens[J].Veterinary Immunology and Immunopathology,2008,(1-2):64-73.
  • 7Ferrari A,Rodríguez M M,Power P. Immunobiological role of llama heavy-chain antibodies against a bacterial β-lactamase[J].Veterinary Immunology and Immunopathology,2007.173-182.
  • 8Garmendia A E,Palmer G H,DeMartini J C. Failure of passive immunoglobulin transfer:a major determinant of mortality in newborn alpacas (Lama pacos)[J].American Journal of Veterinary Research,1987.1472-1476.
  • 9Genst E D,Saeren D,Muylderman S. Antibody repertoire development in camelids[J].Developmental and Comparative Immunology,2006.187-198.
  • 10Ghahroudi M A,Desmyter A,Wyns L. Selection and identification of single domain antibody fragment from camel heavychain antibodies[J].FEBS Letters,1997.521-526.

二级参考文献28

  • 1曹文尧,李江伟,吕芳,侯秋莲,张富春.丹毒丝菌spaA基因免疫保护区的克隆与功能研究[J].中国预防兽医学报,2007,29(7):496-500. 被引量:5
  • 2C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, Bajyana Songa E, Bendahman N, Hamers R. Naturally occurring antibodies devoid of light chains. Nature, 1993, 363(6428): 446-448.
  • 3Muyldermans S, Cambillau C, Wyns L. Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains. Trends in Biochemical Sciences, 2001, 26(4): 230-235.
  • 4Simmons D P, Abregu F A, Krishnan U V, Proll D F, Streltsov V A, Doughty L, Hattarki M K, Nuttall S D. Dimerisation strategies for shark IgNAR single domain antibody fragments. Journal of Immunological Method, 2006, 315:171-184.
  • 5Streltsov V A, Varghese J N, Carmichael J A, Irving R A, Hudson P J, Nuttall S D. Structural evidence for evolution of shark Ig new antigen receptor variable domain antibodies from a cell-surface receptor. Proceedings of the National Academy of Sciences, 2004, 101(34), 12444-12449.
  • 6De Genst E, Silence K, Decanniere K, Conrath K, Loris R, Kinne J, Muyldermans S, Wyns L. Molecular basis for the preferential cleft, recognition by dromedary heavy-chain antibodies. Proceedings of the National Academy of Sciences, 2006, 103(12): 4586-4591.
  • 7Decanniere K, Transue T R, Desmyter A, Maes D, Muyldermans S,Wyns L. Degenerate interfaces in antigen-antibody complexes. Journal of Molecular Biology, 2001, 313: 473-478.
  • 8Lauwereys M, Ghahroudi M A, Desmyter A, Kinne J, HOzer W, De Genst E, Wyns L, Muyldermans S. Potent enzyme inhibitors derived from dromedary heavy-chain antibodies. The European Molecular Biology Organization Journal, 1998, 17(13): 3512-3520.
  • 9Conrath K E, Wernery U, Muyldermans S, Nguyen V K. Emergence and evolution of functional heavy-chain antibodies in Camelidae. Developmental and Comparative Immunology, 2003, 27: 87-103.
  • 10Rahbarizadeh F, Rasaee M J, Forouzandeh-Moghadam M, Allameh A A. High expression and purification of the recombinant camelid anti-MUC1 single domain antibodies in Escherichia coli. Protein Expression and Purification, 2005, 44: 32-38.

共引文献6

同被引文献32

  • 1吉日木图,张和平,赵电波.内蒙古阿拉善双峰驼驼乳IgG的分离纯化及其热稳定性研究[J].食品科学,2006,27(10):188-192. 被引量:7
  • 2王宏博,高雅琴,李维红,梁丽娜,常玉兰.骆驼生产性能及骆驼绒毛品质研究现状[J].当代畜牧,2007,36(7):50-51. 被引量:11
  • 3Soltanian S, Matin M M. Cancer stem ceils and cancer therapy. Tumor Biol, 2011, 32(3) : 425-440.
  • 4Jin X, Jung J E, Beck S,et al. Cell surface Nestin is a biomarker for glioma stem cells. Biochem Biophys Res Commun, 2013, 433 (4) : 496-501.
  • 5Boman B M, Wicha M S. Cancer stem cells: a step toward the cure . Clin Oncol, 2008, 26( 17): 2795-2799.
  • 6Ferrandina G, Petrillo M, Bonanno G,et al. Targeting CD133 antigen in cancer. Expert Opin Ther Targets, 2009, 13 (7) : 823- 837.
  • 7Bao S, Wu Q, McLendon R E, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 2006, 444: 756-760.
  • 8Naujokat C. Monoclanal antibodies against human cancer stem cells. Immunotherapy, 2014, 6(3): 290-308.
  • 9Smith L M, Nesterova A, Ryan M C, et al. CD133/pmminin-I is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. Br J Cancer, 2008, 99 ( 1 ) : 100-109.
  • 10Akita M, Tanaka K, Mural N, et al. Detection of CD133 ( prominin-1 ) in a human hepatoblastoma cell line ( HUH-6 clone 5). Microsc Res Tech, 2013, 76(8) : 844-852.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部